Two Eli Lilly manufacturing plants in Indiana are getting a $5.3 billion boost to increase production of Zepbound and Mounjaro, the company said May 24.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Eli Lilly commits $5.3B to more Zepbound, Mounjaro production
